Lessee, Operating Lease, Liability, to be Paid, Year Three in USD of Propanc Biopharma, Inc. from Q2 2022 to Q2 2025
-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).
-
Summary
-
Propanc Biopharma, Inc. quarterly Lessee, Operating Lease, Liability, to be Paid, Year Three history and change rate from Q2 2022 to Q2 2025.
- Propanc Biopharma, Inc. Lessee, Operating Lease, Liability, to be Paid, Year Three for the quarter ending 30 Jun 2025 was $21.7K.
Lessee, Operating Lease, Liability, to be Paid, Year Three, Quarterly (USD)